| Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer: results of a multicentric phase II trial V Fonteyne, P Dirix, C Van Praet, C Berghen, M Albersen, S Junius, ... European Urology Focus 8 (5), 1238-1245, 2022 | 18 | 2022 |
| Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial F Verghote, L Poppe, S Verbeke, P Dirix, M Albersen, G De Meerleer, ... BMC cancer 21, 1-7, 2021 | 13 | 2021 |
| International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy: update from an IBIS workgroup F Verghote, P Sargos, JP Christodouleas, V Murthy, BC Baumann, P Dirix, ... Practical Radiation Oncology 12 (6), 524-532, 2022 | 10 | 2022 |
| Radiotherapy use in muscle-invasive bladder cancer: review of the guidelines and impact of increased awareness in patient referral at a tertiary center in Belgium F Verghote, C Van Praet, D De Maeseneer, C Berquin, B Vanneste, ... Cancer Management and Research, 511-521, 2023 | 4 | 2023 |
| Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice F Verghote, C Van Praet, C Berquin, N Lumen, K Decaestecker, ... BMC cancer 24 (1), 160, 2024 | 1 | 2024 |
| Can PET-CT improve the staging and outcome of patients with muscle-invasive bladder cancer? V Fonteyne, F Verghote, C Berquin, D De Maeseneer, G Villeirs, ... AME Clinical Trials Review, 2024 | | 2024 |
| 277: Adjuvant EBRT for muscle-invasive bladder cancer: phase 2 trial secondary analysis (NCT02397434) F Verghote, P Dirix, C Van Praet, C Berghen, B Vanneste, S Junius, ... Radiotherapy and Oncology 194, S2308-S2311, 2024 | | 2024 |
| Indicaties voor radiotherapie bij blaaskanker met spierinvasie F Verghote, C Van Praet, D De Maeseneer, C Berquin, B Vanneste, ... ONCO HEMATO 17 (7), 6-10, 2023 | | 2023 |
| Role of radiotherapy as primary treatment for muscle-invasive bladder cancer: review of the guidelines and single-centre pattern of care analysis F Verghote, C Van Praet, D De Maeseneer, C Berquin, B Vanneste, ... 10th Belgian Multidisciplinary meeting on Urological Cancers (BMUC 2023), 2023 | | 2023 |
| Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: results of a phase 2 trial F Verghote, P Dirix, C Van Praet, C Berghen, M Albersen, S Junius, ... Global Congress on Bladder Cancer 2021, 10-10, 2021 | | 2021 |
